402 related articles for article (PubMed ID: 21834608)
1. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
[TBL] [Abstract][Full Text] [Related]
2. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation.
Smith LM; Qureshi N; Chao CR
J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829
[TBL] [Abstract][Full Text] [Related]
3. Low gestational age and chronic lung disease are synergistic risk factors for retinopathy of prematurity.
Giapros V; Drougia A; Asproudis I; Theocharis P; Andronikou S
Early Hum Dev; 2011 Oct; 87(10):653-7. PubMed ID: 21621351
[TBL] [Abstract][Full Text] [Related]
4. Umbilical artery pH may be a possible confounder for neonatal adverse outcomes in preterm infants exposed to antenatal magnesium.
Shimada E; Ogawa M; Matsuda Y; Mitani M; Matsui H
J Matern Fetal Neonatal Med; 2013 Feb; 26(3):270-4. PubMed ID: 23020646
[TBL] [Abstract][Full Text] [Related]
5. Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates.
Katayama Y; Minami H; Enomoto M; Takano T; Hayashi S; Lee YK
J Perinatol; 2011 Jan; 31(1):21-4. PubMed ID: 20505743
[TBL] [Abstract][Full Text] [Related]
6. The combined maternal administration of magnesium sulfate and aminophylline reduces intraventricular hemorrhage in very preterm neonates.
Di Renzo GC; Mignosa M; Gerli S; Burnelli L; Luzi G; Clerici G; Taddei F; Marinelli D; Bragetti P; Mezzetti D; Della Torre B; Fantauzzi A; Lungarotti MS
Am J Obstet Gynecol; 2005 Feb; 192(2):433-8. PubMed ID: 15695983
[TBL] [Abstract][Full Text] [Related]
7. Severe intraventricular hemorrhage in preterm infants: comparison of risk factors and short-term neonatal morbidities between grade 3 and grade 4 intraventricular hemorrhage.
Sarkar S; Bhagat I; Dechert R; Schumacher RE; Donn SM
Am J Perinatol; 2009 Jun; 26(6):419-24. PubMed ID: 19267317
[TBL] [Abstract][Full Text] [Related]
8. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.
del moral T; Gonzalez-Quintero VH; Claure N; Vanbuskirk S; Bancalari E
J Perinatol; 2007 Mar; 27(3):154-7. PubMed ID: 17314984
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants.
Costa S; Zecca E; De Luca D; De Carolis MP; Romagnoli C
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825
[TBL] [Abstract][Full Text] [Related]
10. Outcome of 60 neonates who had ARED flow prenatally compared with a matched control group of appropriate-for-gestational age preterm neonates.
Hartung J; Kalache KD; Heyna C; Heling KS; Kuhlig M; Wauer R; Bollmann R; Chaoui R
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):566-72. PubMed ID: 15912526
[TBL] [Abstract][Full Text] [Related]
11. Perinatal intervention and neonatal outcomes near the limit of viability.
Louis JM; Ehrenberg HM; Collin MF; Mercer BM
Am J Obstet Gynecol; 2004 Oct; 191(4):1398-402. PubMed ID: 15507972
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality patterns in small-for-gestational age infants born preterm.
Giapros V; Drougia A; Krallis N; Theocharis P; Andronikou S
J Matern Fetal Neonatal Med; 2012 Feb; 25(2):153-7. PubMed ID: 21463210
[TBL] [Abstract][Full Text] [Related]
13. Mid- and long-term outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors.
Valcamonico A; Accorsi P; Sanzeni C; Martelli P; La Boria P; Cavazza A; Frusca T
J Matern Fetal Neonatal Med; 2007 Jun; 20(6):465-71. PubMed ID: 17674256
[TBL] [Abstract][Full Text] [Related]
14. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
[TBL] [Abstract][Full Text] [Related]
15. Effects of maternal cervical incompetence on morbidity and mortality of very low birthweight neonates.
Sung TJ; Lee KY; Ju YS
Neonatology; 2010; 98(2):164-9. PubMed ID: 20234141
[TBL] [Abstract][Full Text] [Related]
16. Maternal obesity and neuroprotective magnesium sulfate.
McPherson J; Smiley S; Stamilio D
Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates].
Woynarowska M; Rutkowska M; Szamotulska K
Med Wieku Rozwoj; 2008; 12(4 Pt 1):933-41. PubMed ID: 19471069
[TBL] [Abstract][Full Text] [Related]
18. Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.
Narasimhulu D; Brown A; Egbert NM; Rojas M; Haberman S; Bhutada A; Minkoff H; Rastogi S
J Perinatol; 2017 Dec; 37(12):1297-1303. PubMed ID: 28981078
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of antenatal steroids in obstetric subgroups.
Elimian A; Verma U; Canterino J; Shah J; Visintainer P; Tejani N
Obstet Gynecol; 1999 Feb; 93(2):174-9. PubMed ID: 9932550
[TBL] [Abstract][Full Text] [Related]
20. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
Marret S; Ancel PY
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
